Development of an efficient strategy to improve HPV immunization coverage in Japan

Asami Yagi(The University of Osaka), Kentaro Shimura(Osaka City University), Yutaka Ueda(Osaka Gakuin University), Junko Saito, Masayuki Sekine(Niigata University Medical and Dental Hospital), Yorihiko Horikoshi, Hiromi Murata(Kansai Medical University), Hidetaka Okada(Kansai Medical University), Tomomi Egawa‐Takata(The University of Osaka), Masaki Mandai(Kyoto University), Kei Hirai(The University of Osaka), Tadashi Kimura(Osaka University), Takayuki Enomoto(Itami City Hospital), Risa Kudoh(Niigata University Medical and Dental Hospital), Hidekatsu Nakai(Kindai University), Tomoyuki Ichimura(Osaka City University), Toshiyuki Sumi(Osaka City University), Yusuke Tanaka(Lithuanian Ornithological Society), Akiko Morimoto, Kiyoshi Yoshino(University of Occupational and Environmental Health Japan), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Yoshito Terai(Osaka Medical and Pharmaceutical University)
BMC Public Health
September 23, 2016
10.1186/s12889-016-3676-7
Cited by 29

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|214
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212